Loette Tablet is a combined oral contraceptive containing Ethinyl Estradiol (0.02 mg) and Levonorgestrel (0.10 mg), indicated for the prevention of pregnancy. Ethinyl Estradiol, a synthetic estrogen, and Levonorgestrel, a synthetic progestin, work synergistically to inhibit ovulation, alter cervical mucus to prevent sperm penetration, and modify the endometrial lining to reduce the likelihood of implantation. Loette is administered orally once daily, preferably at the same time each day, to maintain consistent hormone levels and maximize contraceptive efficacy. This formulation is suitable for women seeking reliable birth control and may also provide benefits such as regulation of menstrual cycles, reduction in menstrual bleeding, and decreased incidence of dysmenorrhea. Contraindications include a history of thromboembolic disorders, hormone-sensitive malignancies, uncontrolled hypertension, and known or suspected pregnancy. Caution is advised in patients with cardiovascular risk factors, liver dysfunction, or a history of migraine with aura. Common adverse effects may include nausea, breast tenderness, headache, and spotting, which often resolve with continued use. Patients should be counseled on the importance of adherence and informed about potential drug interactions that may reduce contraceptive effectiveness. Regular follow-up is recommended to monitor tolerance and address any concerns.